Range Low Price High Price Comment
30 days $14.59 $16.25 Monday, 29th Apr 2024 CPRX stock ended at $15.23. This is 2.28% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 2.07% from a day low at $14.98 to a day high of $15.29.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Mar 24, 2023 $15.88 $16.17 $15.64 $16.12 1 467 055
Mar 23, 2023 $16.47 $16.56 $15.66 $16.02 1 469 012
Mar 22, 2023 $16.74 $16.74 $16.18 $16.21 1 742 069
Mar 21, 2023 $16.65 $16.79 $16.37 $16.53 1 755 002
Mar 20, 2023 $15.96 $16.46 $15.96 $16.40 2 843 185
Mar 17, 2023 $15.65 $16.46 $15.54 $15.92 4 629 775
Mar 16, 2023 $14.47 $16.33 $13.87 $15.75 3 312 745
Mar 15, 2023 $14.80 $14.80 $14.14 $14.34 2 736 402
Mar 14, 2023 $14.81 $15.32 $14.69 $14.85 1 601 058
Mar 13, 2023 $14.45 $15.19 $14.42 $14.63 1 780 446
Mar 10, 2023 $15.05 $15.23 $14.37 $14.64 2 606 444
Mar 09, 2023 $15.26 $15.45 $14.93 $15.05 1 834 075
Mar 08, 2023 $15.21 $15.38 $15.13 $15.34 1 247 841
Mar 07, 2023 $15.15 $15.31 $15.02 $15.15 1 372 046
Mar 06, 2023 $15.40 $15.45 $14.93 $15.10 1 581 070
Mar 03, 2023 $15.31 $15.63 $15.22 $15.45 856 163
Mar 02, 2023 $15.36 $15.62 $15.03 $15.30 993 606
Mar 01, 2023 $15.49 $15.58 $15.25 $15.46 1 027 789
Feb 28, 2023 $15.44 $15.58 $15.24 $15.26 987 379
Feb 27, 2023 $15.35 $15.57 $15.25 $15.38 1 383 020
Feb 24, 2023 $15.22 $15.57 $15.11 $15.26 1 099 756
Feb 23, 2023 $15.47 $15.49 $15.15 $15.28 1 702 738
Feb 22, 2023 $15.31 $15.46 $15.19 $15.38 1 237 936
Feb 21, 2023 $15.47 $15.54 $15.21 $15.25 2 229 715
Feb 17, 2023 $15.26 $15.69 $15.04 $15.52 2 274 125
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT